全文获取类型
收费全文 | 84620篇 |
免费 | 4017篇 |
国内免费 | 52篇 |
专业分类
林业 | 3325篇 |
农学 | 2322篇 |
基础科学 | 565篇 |
9519篇 | |
综合类 | 17762篇 |
农作物 | 3283篇 |
水产渔业 | 3581篇 |
畜牧兽医 | 42620篇 |
园艺 | 899篇 |
植物保护 | 4813篇 |
出版年
2018年 | 908篇 |
2017年 | 1027篇 |
2016年 | 983篇 |
2014年 | 970篇 |
2013年 | 2752篇 |
2012年 | 1912篇 |
2011年 | 2299篇 |
2010年 | 1552篇 |
2009年 | 1514篇 |
2008年 | 2300篇 |
2007年 | 2214篇 |
2006年 | 2098篇 |
2005年 | 2038篇 |
2004年 | 1905篇 |
2003年 | 2031篇 |
2002年 | 1886篇 |
2001年 | 2203篇 |
2000年 | 2184篇 |
1999年 | 1764篇 |
1998年 | 776篇 |
1997年 | 789篇 |
1995年 | 821篇 |
1993年 | 770篇 |
1992年 | 1689篇 |
1991年 | 1841篇 |
1990年 | 1815篇 |
1989年 | 1834篇 |
1988年 | 1728篇 |
1987年 | 1693篇 |
1986年 | 1694篇 |
1985年 | 1683篇 |
1984年 | 1436篇 |
1983年 | 1258篇 |
1982年 | 927篇 |
1981年 | 853篇 |
1980年 | 811篇 |
1979年 | 1471篇 |
1978年 | 1172篇 |
1977年 | 1070篇 |
1976年 | 1034篇 |
1975年 | 1141篇 |
1974年 | 1411篇 |
1973年 | 1322篇 |
1972年 | 1380篇 |
1971年 | 1287篇 |
1970年 | 1211篇 |
1969年 | 1140篇 |
1968年 | 956篇 |
1967年 | 1143篇 |
1966年 | 968篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
In vitro anti‐LPS dose determination of ketorolac tromethamine and in vivo safety of repeated dosing in healthy horses 下载免费PDF全文
A. W. Bianco G. E. Moore B. R. Cooper S. D. Taylor 《Journal of veterinary pharmacology and therapeutics》2018,41(1):98-104
Flunixin meglumine (FM) is a commonly used Nonsteroidal anti‐inflammatory drug (NSAID) in horses, but clinical efficacy is often unsatisfactory. Ketorolac tromethamine (KT) demonstrates superior efficacy compared to other NSAIDs in humans, but its anti‐inflammatory effects have not been investigated in the horse. Safety of repeated dosing of KT has not been evaluated. The first objective was to conduct a dose determination study to verify that a previously described dosage of KT would inhibit Lipopolysaccharide (LPS)‐induced eicosanoid production in vitro, and to compare KT effects of this inhibition to those of FM. Then, a randomized crossover study was performed using nine healthy horses to evaluate plasma concentrations of KT and FM following IV administration. Administered dosages of KT and FM were 0.5 mg/kg and 1.1 mg/kg, respectively. Safety following six repeated doses of KT was assessed. Ketorolac tromethamine and FM suppressed LPS‐induced Thromboxane B2 (TXB2) and Prostaglandin E2 (PGE2) production in vitro for up to 12 hr. Intravenous administration produced plasma concentrations of KT and FM similar to previous reports. No adverse effects were observed. A KT dosage of 0.5 mg/kg IV inhibited LPS‐induced eicosanoids in vitro, and repeated dosing for up to 3 days appears safe in healthy horses. Investigation of in vivo anti‐inflammatory and analgesic effects of KT is warranted. 相似文献
993.
P. K. Randleff-Rasmussen A. Leblond J. Cappelle J. Bontemps S. Belluco M. R. Popoff C. Marcillaud-Pitel J. Tapprest P. Tritz I. Desjardins 《Veterinary research communications》2018,42(1):19-27
Equine grass sickness (EGS) (equine dysautonomia) is a neurodegenerative condition of grazing equines. Pre-mortem diagnosis of EGS is a challenge for practitioners as definitive diagnosis requires ileal/myenteric lymph node biopsies. This study aimed to develop a clinical score that could be used by practitioners to improve the detection of acute or subacute EGS cases in the field. Suspected EGS cases were declared by veterinary practitioners. A case was classified as confirmed positive if ileal or rectal biopsy samples showed neuronal degeneration typical of EGS. A semi-quantitative scoring system, including epidemiological and clinical data, was created to attempt to classify suspected EGS horses into confirmed positive or negative cases. Each variable was weighted based on a boosted regression trees model, while taking into account its clinical relevance. Twenty-eight EGS cases were confirmed by biopsy during the entire study period. The best cut-off value for the score to have a high sensitivity while maximizing specificity was 8, with a sensitivity of 100% and a specificity of 53%. In our dataset, 77% of animals would be correctly classified with this cut-off value of 8. Highest sensitivity was chosen in order to detect the highest number of potential cases. Our score represents an inexpensive and useful tool to aid in the identification of suspected EGS cases in the field and selection for further diagnostics procedures to confirm or rule out the disease. Application of the score to larger populations of animals would be required to further adapt and refine the score. 相似文献
994.
995.
996.
997.
E. Biasibetti E. Martello M. Bigliati I. Biasato T. Cocca N. Bruni M. T. Capucchio 《Veterinary research communications》2018,42(2):161-167
Chronic kidney disease (CKD) is a very common disorder in elderly cats. A proper renal diet represents the most efficient therapeutic intervention to improve survival and life quality in feline patients with 3 and 4 International Renal Interest Society (IRIS) stages. Twenty cats were selected in this study. Ten were administered the dietary supplementation for 360 days and the other ten, whose owners did not give consent for any supplemental therapies apart from the renal diet, were selected from a clinical database and used as control group. The present study is a long term study (360 days) aiming to evaluate the efficacy and palatability of a dietary supplementation containing calcium carbonate, calcium-lactate gluconate, chitosan and sodium bicarbonate in cats diagnosed with 3 and 4 IRIS stages of CKD. The owners were asked to fill in questionnaires to get information on the cat’s appetite, the palatability of the given supplement, the presence of vomit and/or diarrhoea, general health and vitality. Hematochemical, biochemical and urinary analyses were performed on day 0, 30, 60, 90, 120, 150,180 and 360. GraphPad Prism® software was used to perform statistical analysis. Our study shows that the given dietary supplement reduced serum phosphorus and increased serum bicarbonate values in cats with CKD. In turn, this supplement could be used as a support therapy in cats with advanced CKD improving their clinical conditions without any adverse reaction. Finally, it is important to underline that all the animals completed the study and the owners reported a good palatability of the feed supplement. 相似文献
998.
999.
1000.
Feray Alkan S. Bilge-Dagalp Z. Karapınar M. O. Timurkan N. Coskun I. Burgu 《Tropical animal health and production》2018,50(2):353-363
A follow-up study from 2005 to 2010 was carried out in two herds where eradication programme for the bovine herpes virus-1 (BoHV-1) infection depends on the vaccination with inactivated glycoprotein E-deleted vaccine that was started in 2001 following the vaccination with inactivated conventional vaccine between 1999 and 2001. For serological screening, a total of 12,976 sera sampled over several sampling times approximately 6 months of interval during 5 years (2005–2010) were tested for glycoprotein E (gE)- and glycoprotein B-specific antibodies using ELISA. According to the serological evidence, the long-term persistence of BoHV-1 antibodies, success of marker vaccine, first vaccination time of the calves in herds regularly vaccinated, etc. were discussed in this paper. In conclusion, the vaccination programme using gE (?) marker vaccines, with making efforts to prevent the other factors about transmission of infection, was suggested for the eradication of BoHV-1 infection in Turkey as many EU countries. This is the first report on the BoHV-1 eradication programme in some dairy cattle in Turkey. 相似文献